BSGM

BioSig Technologies

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 3

Sell signal 1

stock price surged significantly

consensus rating "Strong Buy"

EPS Beats Expectation

RSI Overbought

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About BSGM

Biosig Technologies, Inc.

An advanced digital signal processing technology company focused on the treatment of cardiovascular arrhythmias

Industry

Healthcare Equipment and Supplies

Established Date

02/24/2009

Listing Date

10/23/2024

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.biosig.com

Security Type

Common stock

Office address

55 Greens Farms Road, 1st Floor, Westport, CT 06880

Business

Introduction

BioSig Technologies, Inc., was incorporated under the laws of Nevada on February 24, 2009 and subsequently re-incorporated in Delaware in 2011. The company is a medical device company with an advanced digital signal processing technology platform that provides insights into the treatment of cardiovascular arrhythmias. The Company's initial focus was to provide intracardiac signaling information to electrophysiologists during EP studies and catheter ablation of AF and VT. The company's first product is the PURE (Precise Uninterrupted Real-time Assessment of Electronic Graphs) EP System, a surface ECG and intracardiac multi-channel recording and analysis system that captures, processes and displays ECG and electrograms required in electrophysiological studies and catheter ablation.

Company Financials

EPS

BSGM has released its 2023 Q3 earnings. EPS was reported at -0.06, versus the expected -0.09, beating expectations. The chart below visualizes how BSGM has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

BSGM has released its 2024 Q4 earnings report, with revenue of 13.00K, reflecting a YoY change of 8.33%, and net profit of -1.10M, showing a YoY change of 82.07%. The Sankey diagram below clearly presents BSGM’s revenue sources and cost distribution.